High mobility group box chromosomal protein 1 acts as a proliferation signal for activated T lymphocytes

Immunobiology

Volumn 214, Issue 4, 2009, Pages 303-309

  Sundberg, Erik ^a   Fasth, Andreas E R ^a   Palmblad, Karin ^a   Harris, Helena Erlandsson ^a   Andersson, Ulf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adaptive immunity; Co stimulation; HMGB1; Proliferation; T cells

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MONOCLONAL ANTIBODY CD3; RECOMBINANT PROTEIN;

ADAPTIVE IMMUNITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FLOW CYTOMETRY; HMGB1 PROTEIN; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; RECOMBINANT PROTEINS;

EID: 62749128095     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2008.09.006     Document Type: Article

References (32)

1. Abraham E., Arcaroli J., Carmody A., Wang H., and Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 165 6 (2000) 2950-2954
2. Andersson U., Wang H., Palmblad K., Aveberger A.C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., and Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192 4 (2000) 565-570
3. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D.M., and Nawroth P.P. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83 11 (2005) 876-886
4. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., and Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. Embo J. 22 20 (2003) 5551-5560
5. Bustin M., and Soares N. Differential binding of chromosomal proteins HMG1 and HMG2 to superhelical DNA. Biochem. Biophys. Res. Commun. 133 2 (1985) 633-640
6. Carroll L., Frazer I.H., Turner M., Marwick T.H., and Thomas R. Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis. Arthritis Res. Ther. 9 2 (2007) R39
7. Chen Y., Yan S.S., Colgan J., Zhang H.P., Luban J., Schmidt A.M., Stern D., and Herold K.C. Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J. Immunol. 173 2 (2004) 1399-1405
8. Degryse B., Bonaldi T., Scaffidi P., Muller S., Resnati M., Sanvito F., Arrigoni G., and Bianchi M.E. The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J. Cell Biol. 152 6 (2001) 1197-1206
9. Dumitriu I.E., Baruah P., Valentinis B., Voll R.E., Herrmann M., Nawroth P.P., Arnold B., Bianchi M.E., Manfredi A.A., and Rovere-Querini P. Release of high mobility group box 1 by dendritic cells controls T-cell activation via the receptor for advanced glycation end products. J. Immunol. 174 12 (2005) 7506-7515
10. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., and Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3 10 (2002) 995-1001
11. Han J., Zhong J., Wei W., Wang Y., Huang Y., Yang P., Purohit S., Dong Z., Wang M.H., She J.X., Gong F., Stern D.M., and Wang C.Y. Extracellular HMGB1 acts as an innate immune-mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 57 8 (2008) 2118-2127
12. Hofmann M.A., Drury S., Hudson B.I., Gleason M.R., Qu W., Lu Y., Lalla E., Chitnis S., Monteiro J., Stickland M.H., Bucciarelli L.G., Moser B., Moxley G., Itescu S., Grant P.J., Gregersen P.K., Stern D.M., and Schmidt A.M. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun. 3 3 (2002) 123-135
13. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J. Biol. Chem. 270 43 (1995) 25752-25761
14. Huang Y., Yin H., Han J., Huang B., Xu J., Zheng F., Tan Z., Fang M., Rui L., Chen D., Wang S., Zheng X., Wang C.Y., and Gong F. Extracellular HMGB1 functions as an innate immune-mediator implicated in murine cardiac allograft acute rejection. Am. J. Transplant. 7 4 (2007) 799-808
15. Hudson B.I., and Schmidt A.M. RAGE: a novel target for drug intervention in diabetic vascular disease. Pharm. Res. 21 7 (2004) 1079-1086
16. Klune J.R., Dhupar R., Cardinal J., Billiar T.R., and Tsung A. HMGB1: endogenous danger signaling. Mol. Med. 14 7-8 (2008) 476-484
17. Kokkola R., Li J., Sundberg E., Aveberger A.C., Palmblad K., Yang H., Tracey K.J., Andersson U., and H.E. H. Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity. Arthritis Rheum. 48 7 (2003) 2052-2058
18. Limana F., Germani A., Zacheo A., Kajstura J., Di Carlo A., Borsellino G., Leoni O., Palumbo R., Battistini L., Rastaldo R., Muller S., Pompilio G., Anversa P., Bianchi M.E., and Capogrossi M.C. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ. Res. 97 8 (2005) e73-e83
19. Manfredi A.A., Capobianco A., Esposito A., De Cobelli F., Canu T., Monno A., Raucci A., Sanvito F., Doglioni C., Nawroth P.P., Bierhaus A., Bianchi M.E., Rovere-Querini P., and Del Maschio A. Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. J. Immunol. 180 4 (2008) 2270-2275
20. Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., Tracey K.J., and Chiorazzi N. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J. Immunol. 173 1 (2004) 307-313
21. Moser B., Desai D.D., Downie M.P., Chen Y., Yan S.F., Herold K., Schmidt A.M., and Clynes R. Receptor for advanced glycation end products expression on T cells contributes to antigen-specific cellular expansion in vivo. J. Immunol. 179 12 (2007) 8051-8058
22. Moser B., Szabolcs M.J., Ankersmit H.J., Lu Y., Qu W., Weinberg A., Herold K.C., and Schmidt A.M. Blockade of RAGE suppresses alloimmune reactions in vitro and delays allograft rejection in murine heart transplantation. Am. J. Transplant. 7 2 (2007) 293-302
23. Park J.S., Arcaroli J., Yum H.K., Yang H., Wang H., Yang K.Y., Choe K.H., Strassheim D., Pitts T.M., Tracey K.J., and Abraham E. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 284 4 (2003) C870-C879
24. Pil P.M., Chow C.S., and Lippard S.J. High-mobility-group 1 protein mediates DNA bending as determined by ring closures. Proc. Natl. Acad. Sci. USA 90 20 (1993) 9465-9469
25. Rendon-Mitchell B., Ochani M., Li J., Han J., Wang H., Yang H., Susarla S., Czura C., Mitchell R.A., Chen G., Sama A.E., Tracey K.J., and Wang H. IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J. Immunol. 170 7 (2003) 3890-3897
26. Rouhiainen A., Kuja-Panula J., Wilkman E., Pakkanen J., Stenfors J., Tuominen R.K., Lepantalo M., Carpen O., Parkkinen J., and Rauvala H. Regulation of monocyte migration by amphoterin (HMGB1). Blood 104 4 (2004) 1174-1182
27. Rovere-Querini P., Capobianco A., Scaffidi P., Valentinis B., Catalanotti F., Giazzon M., Dumitriu I.E., Muller S., Iannacone M., Traversari C., Bianchi M.E., and Manfredi A.A. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5 8 (2004) 825-830
28. Scaffidi P., Misteli T., and Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 6894 (2002) 191-195
29. Van de Wouwer M., Plaisance S., De Vriese A., Waelkens E., Collen D., Persson J., Daha M.R., and Conway E.M. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J. Thromb. Haemostasis 4 8 (2006) 1813-1824
30. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., and Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 5425 (1999) 248-251
31. Wang H., Yang H., Czura C.J., Sama A.E., and Tracey K.J. HMGB1 as a late mediator of lethal systemic inflammation. Am. J. Respir. Crit. Care Med. 164 10 Pt 1 (2001) 1768-1773
32. Yang D., Chen Q., Yang H., Tracey K.J., Bustin M., and Oppenheim J.J. High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J. Leukoc. Biol. 81 1 (2007) 59-66